FDA Issues News Release on Expanded Use of Gardasil 9

Oct 12, 2018 | Kimberly Sharpe-Scott

On October 5, 2018, the U.S. Food and Drug Administration (FDA) issued a news release to announce the administration’s approval of the expanded use of Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) to include women and men aged 27 through 45 years of age. Gardasil 9, which protects against nine HPV types, was originally approved by the FDA in 2014 for use in males and females aged 9 through 26 years.

Peter Marks, MD, PhD, Director of the FDA’s Center for Biologics Evaluation and Research, stated, “Today’s approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range. The Centers for Disease Control and Prevention has stated that HPV vaccination prior to becoming infected with the HPV types covered by the vaccine has the potential to prevent more than 90 percent of these cancers, or 31,200 cases every year, from ever developing.”

For more information, view the news release, FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. To access additional information regarding Gardasil 9 and recent updates, visit


About Kimberly Sharpe-Scott

More posts by Kimberly Sharpe-Scott

Related Posts

Young asian girl getting vaccine
  • Immunization

Innovative Ways to Maintain Immunization Coverage during...

To close the workgroup year, NACCHO’s Immunization Workgroup reflected on the...

Jul 31, 2020 | Amy Frandsen

Innovative Ways to Maintain Immunization Coverage during...

  • Awards & Recognition

NACCHO’s Project Public Health Ready Recognizes 26...

NACCHO’s Project Public Health Ready (PPHR) is pleased to recognize 26 agencies...

Jul 30, 2020 | Beth Hess

NACCHO’s Project Public Health Ready Recognizes 26...

  • COVID-19
  • HIV, STI, & Viral Hepatitis

HIV Care and Coronavirus (COVID-19): Info and HHS/CDC...

TheBodyPro has developed a repository of information about the intersection of...

Jul 29, 2020 | Julia Zigman (she/her)

HIV Care and Coronavirus (COVID-19): Info and HHS/CDC...

Cdc badge small
  • COVID-19
  • HIV, STI, & Viral Hepatitis
  • Infectious Disease

Interim Guidance for Use of Pooling Procedures in...

The CDC recently released interim guidance for use of pooled testing for...

Jul 29, 2020 | Julia Zigman (she/her)

Interim Guidance for Use of Pooling Procedures in...

NCSH small
  • COVID-19
  • HIV, STI, & Viral Hepatitis

Fact Sheet: How Can LGBTQ+ Youth Navigate COVID-19?

The National Coalition for Sexual Health and GLSEN released a new fact sheet,...

Jul 29, 2020 | Kat Kelley

Fact Sheet: How Can LGBTQ+ Youth Navigate COVID-19?

  • Tools & Resources
  • HIV, STI, & Viral Hepatitis

WHO Says COVID-19 Threatens Gains on Hepatitis, Releases...

WHO released new guidelines for preventing mother-to-child transmission of...

Jul 29, 2020 | Julia Zigman (she/her)

WHO Says COVID-19 Threatens Gains on Hepatitis, Releases...

  • COVID-19
  • HIV, STI, & Viral Hepatitis
  • Opioid Overdose Epidemic

Report: COVID-19 Could Lead to a Surge in Overdose Deaths

A recent article in Hep Magazine warns that the COVID-19 pandemic could worsen...

Jul 29, 2020 | Julia Zigman (she/her)

Report: COVID-19 Could Lead to a Surge in Overdose Deaths

  • COVID-19
  • HIV, STI, & Viral Hepatitis

Report: The Impact of COVID-19 on Hepatitis Elimination

The World Hepatitis Alliance published the findings of a global survey to...

Jul 29, 2020 | Julia Zigman (she/her)

Report: The Impact of COVID-19 on Hepatitis Elimination

The Toolkit for HAP E cover jpg
  • Press Release
  • Tools & Resources
  • Health in All Policies
  • Parks

New Resource for Local Health Departments Features...

NACCHO announces the launch of The Toolkit for Health, Arts, Parks, and Equity...

Jul 28, 2020 | Andrea Grenadier

New Resource for Local Health Departments Features...

Back to Top